Zobrazeno 1 - 10
of 1 585
pro vyhledávání: '"Montefusco V."'
Autor:
Noia A; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Romano F; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Fiorillo G; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Montefusco V; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Muoio R; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Caprio L; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Rufo C; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Santoriello C; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Termoli G; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Vitolo M; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno., Pagano AM; UOSD Tutela Salute Adulti e Minori Area Penale, ASL Salerno.
Publikováno v:
Rivista di psichiatria [Riv Psichiatr] 2024 Jul-Aug; Vol. 59 (4), pp. 157-167.
Publikováno v:
In Clinical Neurophysiology April 2016 127(4):2149-2160
Autor:
Cinetto F; Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Department of Medicine - DIMED, University of Padova, Treviso, Italy., Francisco IE; Hospital de Santa Maria, Lisbon, Portugal., Fenchel K; MVZ Trager GbR, Saalfeld, Germany., Scarpa R; Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Department of Medicine - DIMED, University of Padova, Treviso, Italy., Montefusco V; SSD Onco-Ematologia, ASST Santi Paolo e Carlo, Milan, Italy., Pluta A; National School in Brzozow, Brzozow, Poland., Wolf HM; Immunology Outpatient Clinic, Vienna, Austria.; Sigmund Freud Private University- Medical School, Vienna, Austria.
Publikováno v:
Expert review of hematology [Expert Rev Hematol] 2023 Apr; Vol. 16 (4), pp. 237-243. Date of Electronic Publication: 2023 Apr 03.
Autor:
Marcon C; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Department of Area Medica, Udine University, Udine, Italy., Simeon V; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Department of Area Medica, Udine University, Udine, Italy., Deias P; Division of Hematology and Bone Marrow Transplant Center, Department of Medical Science, R. Binaghi Hospital, Cagliari University, Cagliari, Italy., Facchin G; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy., Corso A; Division of Hematology, Legnano's Hospital, Milan, Italy., Derudas D; Division of Hematology and Bone Marrow Transplant Center, A. Businco Cancer Hospital, Cagliari, Italy., Montefusco V; Division of Hematology, Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e Carlo, Milan, Italy., Offidani M; Clinical Hematology, Azienda Ospedaliera Universitaria (AOU) Ospedali Riuniti di Ancona, Ancona, Italy., Petrucci MT; Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Zambello R; Clinical Hematology, Azienda Ospedaliera di Padova, Padua, Italy., Stocchi R; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy., Fanin R; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Department of Area Medica, Udine University, Udine, Italy., Patriarca F; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Department of Area Medica, Udine University, Udine, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Jan 23; Vol. 12, pp. 1096852. Date of Electronic Publication: 2023 Jan 23 (Print Publication: 2022).
In multiple myeloma, novel treatments with proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs) have prolonged survival but the disease remains incurable. At relapse, next-generation sequencing has shown occasional mutations of drug target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::70f6b47f6865fc2d1c44955d4d4c9aa9
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104641
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104641
Background: The emergence of highly active novel agents has led some to question the role of autologous haematopoietic stem-cell transplantation (HSCT) and subsequent consolidation therapy in newly diagnosed multiple myeloma. We therefore compared au
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0239ec2b87d37fdf26b7139dd667c9a3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121066
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121066
Autor:
Mucci A., Galderisi S., Green M. F., Nuechterlein K., Rucci P., Gibertoni D., Rossi A., Rocca P., Bertolino A., Bucci P., Hellemann G., Spisto M., Palumbo D., Aguglia E., Amodeo G., Amore M., Bellomo A., Brugnoli R., Carpiniello B., Dell'osso L., Di Fabio F., Di Giannantonio M., Di Lorenzo G., Marchesi C., Monteleone P., Montemagni C., Oldani L., Romano R., Roncone R., Stratta P., Tenconi E., Vita A., Zeppegno P., Maj M., Piegari G., Vignapiano A., Caputo F., Plescia G., Montefusco V., Mancini M., Attrotto M. T., Paladini V., Atti A. R., Barlati S., Galluzzo A., Mussoni C., Pinna F., Sanna L., Primavera D., Signorelli M. S., Minutolo G., Cannavo D., Acciavatti T., Santacroce R., Corbo M., Altamura M., La Montagna M., Carnevale R., Pizziconi G., Rossi R., Santarelli V., Giusti L., Malavolta M., Salza A., Murri M. B., Calcagno P., Bugliani M., Serati M., Orsenigo G., Gramaglia C., Gattoni E., Cattaneo C., Campagnola N., Ferronato L., Piovan C., Tonna M., Bettini E., Ossola P., Gesi C., Landi P., Rutigliano G., Biondi M., Girardi P., Buzzanca A., Zocconali M., Comparelli A., Mancinelli I., Niolu C., Ribolsi M., Siracusano A., Corrivetti G., Bartoli L., Diasco F., Bolognesi S., Goracci A., Fagiolini A., Bellino S., Cardillo S., Bracale N.
BackgroundThe increased use of the MATRICS Consensus Cognitive Battery (MCCB) to investigate cognitive dysfunctions in schizophrenia fostered interest in its sensitivity in the context of family studies. As various measures of the same cognitive doma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df0f0f69a1ebb43f612e26b0a0bdcde
http://hdl.handle.net/11591/426233
http://hdl.handle.net/11591/426233
Autor:
Vignapiano, A., Koenig, T., Mucci, A., Giordano, G. M., Amodio, A., Altamura, M., Bellomo, A., Brugnoli, R., Corrivetti, G., Di Lorenzo, G., Girardi, P., Monteleone, P., Niolu, C., Galderisi, S., Maj, M., Piegari, G., Merlotti, E., Plescia, G. M., Montefusco, V., Gallo, O., Romano, P., Carnevale, R., La Montagna, M., Ferrentino, F., Siracusano, A., Comparelli, A., Corigliano, V., Cascino, G., Del Buono, G.
In subjects with schizophrenia (SCZ), the disorganization dimension is a strong predictor of real-life functioning. "Conceptual disorganization" (P2), "Difficulty in abstract thinking" (N5) and "Poor attention" (G11) are core features of the disorgan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defc6f86f549ca8a56c3b830158580fe
http://hdl.handle.net/11573/1350662
http://hdl.handle.net/11573/1350662
Autor:
Manzoni M; Unità di Medicina II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy., Bosi A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Fabris S; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Lionetti M; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Salerio S; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Migliorini AC; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Cavallaro F; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Barbullushi K; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Rampi N; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Montefusco V; Department of Onco-Hematology, ASST Santi Paolo e Carlo, Milan, Italy., Alessio MG; Dipartimento di Analisi Cliniche, ASST Santi Paolo e Carlo, Milan, Italy., Neri A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Baldini L; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Sciumè M; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Tagliaferri E; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Fracchiolla N; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Bolli N; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Publikováno v:
Clinical hematology international [Clin Hematol Int] 2022 May 12; Vol. 4 (1-2), pp. 52-55. Date of Electronic Publication: 2022 May 12 (Print Publication: 2022).